A potent genetic risk factor for restenosis
暂无分享,去创建一个
T. Ogihara | J. Higaki | H. Rakugi | M. Ohishi | T. Miki | K. Fujii | T. Minamino | A. Kamitani | H. Mikami | Yi Zhao
[1] Philippe Amouyel,et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction , 1992, Nature.
[2] Lippincott Williams Wilkins,et al. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angiopla , 1992, Circulation.
[3] P Corvol,et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.
[4] H. Baumgartner,et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. , 1989, Science.